Shares of Mettler-Toledo International Inc. (NYSE:MTD - Get Free Report) have been assigned a consensus rating of "Hold" from the nine analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $1,304.25.
MTD has been the topic of a number of recent research reports. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a report on Monday, February 10th. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a research note on Monday, April 7th. Finally, Robert W. Baird cut their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd.
Get Our Latest Analysis on MTD
Mettler-Toledo International Stock Up 0.0 %
Shares of MTD traded up $0.16 during mid-day trading on Friday, hitting $1,061.95. The stock had a trading volume of 194,880 shares, compared to its average volume of 143,586. Mettler-Toledo International has a fifty-two week low of $889.71 and a fifty-two week high of $1,546.93. The company has a market cap of $22.13 billion, a PE ratio of 26.20, a PEG ratio of 3.30 and a beta of 1.28. The company's fifty day simple moving average is $1,160.03 and its two-hundred day simple moving average is $1,243.85.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Equities analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.
Insider Activity at Mettler-Toledo International
In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the business's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company's stock, valued at approximately $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.
Institutional Investors Weigh In On Mettler-Toledo International
Several hedge funds and other institutional investors have recently bought and sold shares of MTD. SBI Securities Co. Ltd. acquired a new position in shares of Mettler-Toledo International in the 4th quarter worth approximately $33,000. Edmond DE Rothschild Holding S.A. bought a new stake in Mettler-Toledo International during the fourth quarter worth approximately $44,000. Blue Trust Inc. grew its position in Mettler-Toledo International by 70.8% in the fourth quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier's stock worth $50,000 after buying an additional 17 shares during the last quarter. Golden State Wealth Management LLC lifted its position in shares of Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 35 shares during the last quarter. Finally, Whipplewood Advisors LLC bought a new stake in shares of Mettler-Toledo International during the 4th quarter worth $54,000. 95.07% of the stock is currently owned by institutional investors.
About Mettler-Toledo International
(
Get Free ReportMettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.